An analog of human leptin, metreleptin, has been approved in Japan for metabolic disorders including lipodystrophy and in the United States as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy.
An analog of human leptin has been approved in Japan for metabolic disorders including lipodystrophy and in the United States as replacement therapy to treat the complications of leptin deficiency, in addition to diet. This was in patients with congenital generalized. This was in patients with acquired generalized lipodystrophy. An analog of human leptin is metreleptin.